Home > Income Statement > GLENMARK PHARMACEUTICALS

GLENMARK PHARMACEUTICALS
Revenue

    Back to Income Statement
COMMUNITY POLL
for GLENMARK PHARMACEUTICALS
Please provide your vote to see the results

GLENMARK PHARMACEUTICALS Last 5 Year Revenue History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
Net Sales ₹11,813 Cr₹11,583 Cr₹12,305 Cr₹10,944 Cr₹10,641 Cr

What is the latest Revenue of GLENMARK PHARMACEUTICALS ?

The latest Revenue ratio of GLENMARK PHARMACEUTICALS is ₹11,813 Cr based on Mar2025 Consolidated results.
Year Revenue
Mar2025₹11,813 Cr
Mar2024₹11,583 Cr
Mar2023₹12,305 Cr
Mar2022₹10,944 Cr
Mar2021₹10,641 Cr

How is Revenue of GLENMARK PHARMACEUTICALS Trending?

Years Revenue % Change
Mar2025 ₹11,813 Cr
1.98
Mar2024 ₹11,583 Cr
-5.86
Mar2023 ₹12,305 Cr
12.44
Mar2022 ₹10,944 Cr
2.85
Mar2021 ₹10,641 Cr -

Compare Revenue of peers of GLENMARK PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
GLENMARK PHARMACEUTICALS ₹62,222.3 Cr 1.1% -3.1% 29.7% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹446,924.0 Cr -0.3% 3.4% 12.7% Stock Analytics
DIVIS LABORATORIES ₹174,619.0 Cr -2.5% -1.2% -1.1% Stock Analytics
TORRENT PHARMACEUTICALS ₹156,450.0 Cr 2.4% 5.2% 47.2% Stock Analytics
CIPLA ₹118,361.0 Cr 2.2% 4.8% -3% Stock Analytics
DR REDDYS LABORATORIES ₹113,253.0 Cr 4.3% 4.1% 4.5% Stock Analytics


GLENMARK PHARMACEUTICALS Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
GLENMARK PHARMACEUTICALS

1.1%

-3.1%

29.7%

SENSEX

-0.8%

0.8%

-7.2%


You may also like the below Video Courses